Marca Nominativa depositada no INPI em 15/03/2023 por Oncopia Therapeutics, Inc., processo nº 501733085, nas classes 09, 42. Registro em vigor até 15/03/2033.
| Número do processo | 501733085 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 15/03/2023 |
| Data da concessão | 24/06/2025 |
| Vigência até | 15/03/2033 |
| Titular | Oncopia Therapeutics, Inc. |
| CNPJ/CPF do titular | — |
| UF · País | — · US |
Downloadable computer software for use in the field of drug discovery, screenings, and pharmaceuticals; downloadable computer software for use to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; downloadable computer software for use in collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry, clinical trial management and patient engagement.;
Drug discovery services; DNA and protein screening for scientific research purposes; platform as a service (PAAS) featuring computer software platforms for use in the field of drug discovery, screenings, and pharmaceuticals; scientific and technological services and research and design relating thereto; analysis of technical data by computers; pharmaceutical drug discovery services; pharmaceutical and biotechnology research and development services; drug use discovery services; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery; conducting scientific and pharmaceutical research and data analysis to screen for and identify molecular interactions, compounds and detect toxicity; providing scientific, pharmaceutical and agrochemical database research services; scientific and pharmaceutical artificial intelligence research services to identify molecules and compounds for drug discovery and chemical development; bioinformatics services, namely, using the combination of biology, computer science, information engineering, mathematics and statistics to analyze and interpret biological data; computer assisted molecule design; identification of biological targets, networks and pathways; biological research and analysis; pharmaceutical research and development services; computer aided diagnostic and screening services for scientific research purposes; contract research services in support of scientific research and development of pharmaceutical preparations; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501733085 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas6 despacho(s) publicado(s) na Revista da Propriedade Industrial.